Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU.

Vaccine. 2011 Sep 22;29(41):7207-11. doi: 10.1016/j.vaccine.2011.06.056.

2.

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Lancet Infect Dis. 2011 Oct;11(10):760-8. doi: 10.1016/S1473-3099(11)70090-1.

PMID:
21621466
3.

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

Grall N, Hurmic O, Al Nakib M, Longo M, Poyart C, Ploy MC, Varon E, Raymond J; ORP Ile de France Ouest..

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1511-9. doi: 10.1007/s10096-011-1251-9.

PMID:
21499971
4.

Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, Frazão N, Gonçalves-Sousa N, Melo-Cristino J, de Lencastre H, Ramirez M.

J Clin Microbiol. 2011 Apr;49(4):1369-75. doi: 10.1128/JCM.01763-10.

5.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC).; Advisory Committee on Immunization Practices..

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

6.

Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons.

Calatayud L, Ardanuy C, Tubau F, Rolo D, Grau I, Pallarés R, Martín R, Liñares J.

J Clin Microbiol. 2010 Apr;48(4):1310-6. doi: 10.1128/JCM.01868-09.

7.

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.

Liñares J, Ardanuy C, Pallares R, Fenoll A.

Clin Microbiol Infect. 2010 May;16(5):402-10. doi: 10.1111/j.1469-0691.2010.03182.x. Review.

8.

Antibody microarray typing, a novel technique for Streptococcus pneumoniae serotyping.

Marimon JM, Monasterio A, Ercibengoa M, Pascual J, Prieto I, Simón L, Perez-Trallero E.

J Microbiol Methods. 2010 Mar;80(3):274-80. doi: 10.1016/j.mimet.2010.01.011.

PMID:
20093147
9.

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.

Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J.

J Antimicrob Chemother. 2009 Sep;64(3):507-10. doi: 10.1093/jac/dkp210.

10.

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D.

J Clin Microbiol. 2009 Apr;47(4):1012-20. doi: 10.1128/JCM.01454-08.

11.

Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine.

Pérez-Trallero E, Marimon JM, Ercibengoa M, Vicente D, Pérez-Yarza EG.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):731-8. doi: 10.1007/s10096-008-0693-1.

PMID:
19153783
12.

Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.

Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, Grau I, Martín R, Liñares J.

Clin Infect Dis. 2009 Jan 1;48(1):57-64. doi: 10.1086/594125.

13.

Pediatric parapneumonic empyema, Spain.

Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia-Garcia JJ, Hausdorff WP, Brueggemann AB.

Emerg Infect Dis. 2008 Sep;14(9):1390-7. doi: 10.3201/eid1409.071094.

14.

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.

J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996.

15.

Streptococcus pneumoniae serotype 19A in children, South Korea.

Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ.

Emerg Infect Dis. 2008 Feb;14(2):275-81. doi: 10.3201/eid1402.070807.

16.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Brueggemann AB, Pai R, Crook DW, Beall B.

PLoS Pathog. 2007 Nov;3(11):e168.

17.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.

J Infect Dis. 2007 Nov 1;196(9):1346-54.

18.

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstein R, Hanage WP.

Pediatr Infect Dis J. 2007 Jun;26(6):468-72.

PMID:
17529860
19.

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network..

N Engl J Med. 2006 Apr 6;354(14):1455-63. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638.

20.

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.

Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ, Gonzalez AL, Medina MJ, Pai R, Thompson TA, Harrison LH, McGee L, Whitney CG; Active Bacterial Core Surveillance Team..

J Clin Microbiol. 2006 Mar;44(3):999-1017.

Items per page

Supplemental Content

Support Center